Lincoln, NE's Golf Course Revenue Refunding Bonds Rated 'AA+'; Outlook Stable Oct 01

  • ID: 1791192
  • October 2001
  • Standard & Poors
1 of 3

CHICAGO (Standard & Poor's) Oct. 17, 2001--Standard & Poor's today assigned its double-'A'-plus rating to Lincoln, Neb.'s $3.165 million golf course revenue refunding bonds series 2001 dated date of delivery due Aug. 15, 2011. At the same time, Standard & Poor's today affirmed its triple-'A' rating on the city's outstanding GO debt and infrastructure redevelopment fund bonds. The outlook is stable. The rating is based on the city's pledge to annually appropriate money from its general fund to cover debt service payments in the event that golf revenues are insufficient. Because the bonds are not backed by the city's GO pledge, the rating is set one notch below Lincoln's triple-'A' GO rating. The city's GO rating reflects its: -- Large,...

Companies mentioned in this report are:
- Lincoln

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3


Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.